The Patent Finder

Rostaquo S.P.A.

Also on record
Records under this name other than patents Rostaquo S.P.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Rostaquo S.P.A.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,868,7575-β, 14-β-androstane derivatives useful for the treatment of proteinuria, glomerulosclerosis and renal failure
Formerly held
Lapsed on the fee record
Ended Jan 16, 2026 · USPTO record
Lapsed on the fee recordEnded Jan 16, 2026USPTO record
US 9,408,854Methods and systems for pharmacogenomic treatment of cardiovascular conditions
Formerly held
Lapsed on the fee record
Ended Aug 9, 2024 · USPTO record
Lapsed on the fee recordEnded Aug 9, 2024USPTO record
US 9,127,037Crystalline rostafuroxin
Formerly held
Lapsed on the fee record
Ended Sep 8, 2023 · USPTO record
Lapsed on the fee recordEnded Sep 8, 2023USPTO record
US 5,567,69717-(4-Pyridazinyl) -5.beta., 14.beta.-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
Term ended
Term ended no later than Oct 22, 2016 · Low confidence
Term endedTerm ended no later than Oct 22, 2016Low confidence
US 5,591,73417-(3-Furyl)-5.beta., 14.beta.-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
Term ended
Term ended no later than Jan 7, 2017 · Low confidence
Term endedTerm ended no later than Jan 7, 2017Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited